PROVIDER PROFILE · NPI 1871798579
Matthew SurganM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
8,165
Unique beneficiaries
—
Total services
23,213
Distinct HCPCS
41
Medicare payment
$511K
Peer benchmark
Total Medicare services vs. 290 Endocrinology providers in NJ — top quintile (cohort median 1,480).
PRESCRIBING · PART D · 2024
Total Rx claims
5,194
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
48
Brand share
57.0%
Top prescribed drugs
Levothyroxine Sodium515 claims
Semaglutide467 claims
Rosuvastatin Calcium419 claims
Empagliflozin321 claims
Levothyroxine Sodium300 claims
QUALITY · MIPS · 2024
Final MIPS score
99.0
Quality
98.4
Cost
78.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.01%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$555
Payment records
38
By payment type
Food and Beverage$546
Education$9
Top paying entities
Food and Beverage$546
Education$9
REFERRAL NETWORK
Where Matthew Surgan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 79 | 211 |
| Accu Reference Medical Lab, Llc Clinical Laboratory · Linden, NJ | 12 | 31 |
| MICH, ROBERT | 11 | 32 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE